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infarction of the left lower lobe after left single lung trans-
plantation; a left lower lobectomy was undertaken, but the
patient died shortly thereafter.
This is the first reported case of successful bilobectomy
after lung transplantation; it is probable that the satisfactory
performance of the contralateral allograft may have played a
role in the successful outcome.
In conclusion, the occurrence of pulmonary venous
obstruction after lung transplantation is a potentially serious
complication that always requires a surgical approach. The
operation is often technically demanding, as every second
operation is, but the results are highly rewarding; revision and
refashioning of the atrial anastomosis or, as the present case
has shown, major pulmonary resection in the case of irre-
versible lung injury is associated with an excellent outcome.
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Fig 1. Lung perfusion scan performed on postoperative day 8
shows a perfusion defect in the upper half of the right lung
allograft.
Fig 2. Computed tomographic scan performed on postopera-
tive day 9 shows a consolidation of the posterior portion of the
right upper lobe and the lateral segment of the middle lobe.
AGGRESSIVE SURGERY FOR TREATING A PULMONARY METASTASIS OF A BENIGN 
GIANT CELL TUMOR OF THE BONE: RESULTS IN FOUR CASES
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A benign giant cell tumor of the bone (BGCTB) is difficult
to categorize because its clinical course cannot be predicted.
Approximately 50 cases of a pulmonary metastasis from a
BGCTB have been reported in the literature.1 A pulmonary
metastasis from a BGCTB does not necessarily mean a bad
prognosis, but it has been the cause of death in 16% to 25%
of reported cases.2,3 Our method of managing a pulmonary
metastasis of a BGCTB is that it should be treated aggres-
sively, as long as the required operation does not impair pul-
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monary functioning. This article presents our results in treat-
ing 4 patients with pulmonary BGCTB metastasis.
Patients and methods. Forty-seven patients with BGCTB
were treated at our facility between 1979 and 1997. Four of
these patients had a documented pulmonary BGCTB metas-
tasis (Table I). A local recurrence was manifested in all cases.
The interval between the operation for local recurrence and
the subsequent diagnosis of a pulmonary metastasis was 9 to
54 months (average, 37 months). Plain radiographs and com-
puted tomography scans of the chest were used for the local-
ization of the pulmonary nodules.
Results. The lung was found to be the only site of a
metastatic involvement in all 4 patients, who thus under-
went a complete resection their pulmonary metastasis
(Table II). Two of these patients remained tumor-free after
their initial bilateral thoracotomy for their pulmonary metas-
tasis; however, the remaining 2 patients who were surgically
treated (cases 1 and 2) experienced the development of a
metastatic recurrence in the lung. Both patients did not stay
tumor-free after their second thoracotomy and had to under-
go a third thoracotomy. None of the 4 patients were given
chemotherapy or radiotherapy. Each was followed up at 6-
month intervals at which time computed tomography scans
of the chest were performed. After undergoing the surgical
interventions, all patients are still alive (24 to 76 months
after the operation).
Discussion. Although the overall BGCTB survival is much
higher that for other metastasized lung tumors, BGCTB pul-
monary metastasis have been implicated as the cause of
death. The natural history of a BGCTB with pulmonary
metastasis is as unpredictable as that of the primary BGCTB.
On the basis of what is presently known, lesions from
BGCTB pulmonary metastasis can be divided into 3 types:
(1) those that show spontaneous regression or cessation of
growth; (2) those that show continuous slow growth; and (3)
those that show rapid growth. It has been reported that
metastatic lesions of the lung have disappeared after just a
biopsy4 and that some pulmonary lesions spontaneously
regress.1 However, of the few reported cases of an untreated
pulmonary BGCTB metastasis, most patients die quite rapidly
of the disease.4
For therapy, a thoracotomy and a complete excision of the
pulmonary nodules has proved successful,4 and the literature
strongly favors the surgical extirpation of all pulmonary nod-
ules.2 Some studies that included patients with BGCTB that
was treated by operation and whose follow-ups have been
pursued have reported no signs of a BGCTB recurrence at 18
or more years after a resection.2 Another study has also found
that some patients have become asymptomatic, even though
they had a progressive pulmonary disease, and are alive and
well.5 Further, cases have been reported of recurring and pro-
gressive pulmonary metastasis after the surgical removal of
previous pulmonary nodules.2 In this latter regard, it has been
reported that other patients who underwent a partial or a com-
plete excision of their pulmonary nodules also died of the
condition.4 However, a thoracotomy and the complete exci-
sion of recurring, metastatic, pulmonary nodules has been
found beneficial for long-term survival.2
Our management policy for the 4 cases of this study was
a complete extirpation of their pulmonary metastasis, even
for the 2 patients who had repeated metastatic recurrences.
The 2 patients have also remained disease free at 76 months
after the third thoracotomy. As for methods of treatment for
a BGCTB metastasis, radiation has been used without ap-
parent success5 and chemotherapy has only occasionally
proved successful.4 Therefore for cases of recurring lung
metastasis from a BGCTB, we believe that an aggressive
thoracotomy remains the best therapy, provided that the
metastasis can be totally removed without impairing pul-
monary functioning.
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Table I. Patients with pulmonary metastases from a BGCTB: treatment of primary lesion and subsequent local
recurrence
Age/gender Treatment of Time until pulmonary 
Case at diagnosis Primary site Treatment of primary local recurrence metastases diagnosed (mo)
1 30/F Right proximal tibia Curettage, bone graft Above-the-knee amputation 54
2 20/F Left proximal tibia Curettage, bone graft Wide resection 9
3 24/M Right distal radius Curettage, bone graft Wide resection 53
4 15/F Left proximal tibia Curettage, bone graft Wide resection 33
Table II. Treatment of pulmonary metastases and
results
Surgical treatment Follow-up 
Case (thoracotomy) Lung involvement (mo)
1 Left 3 lung nodules 24
Left 3 lung nodules 26
Left 1 lung nodule 76*
2 Right 6 lung nodules 24
Bilateral 5 right lung nodules
24 left lung nodules 28
Right 2 lung nodules 76*
3 Bilateral 1 right lung nodule
1 left lung nodule 39*
4 Bilateral 7 right nodules
13 left nodules 24*
*No evidence of disease.
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IS COMPLETE SYSTEMATIC NODAL DISSECTION BY THORACOSCOPIC SURGERY POSSIBLE? 
A PROSPECTIVE TRIAL OF VIDEO-ASSISTED LOBECTOMY FOR CANCER OF THE RIGHT LUNG
Takashi Kondo, MD, Motoyasu Sagawa, MD, Tatsuo Tanita, MD, Masami Sato, MD, Sadafumi Ono, MD, Yuji Matsumura,
MD, and Shigefumi Fujimura, MD, Sendai, Japan
Recently, video-assisted thoracic surgery (VATS) has been
widely applied to various intrathoracic benign diseases. The
procedure is apparently less invasive than any other conven-
tional standard thoracotomy and is also cosmetically pleasing
to patients. If VATS can be applied to the treatment of prima-
ry lung cancer, numerous benefits for patients can be expect-
ed, even if a small thoracotomy is needed to complete the pul-
monary resection. However, one problem remains in the
application of the procedure for surgical treatment of prima-
ry lung cancer, that is, the possibility of incomplete system-
atic nodal dissection. To clarify the feasibility of sufficient
dissection with VATS, we conducted a prospective clinical
trial in 6 patients with clinical stage I cancer of the right lung.
Patients and methods. Patients with stage I cancer of the
right lung were chosen for the present assessment because the
upper mediastinal and pretracheal nodes can be dissected with-
out the difficulty that is encountered in cancer of the left lung.
Inasmuch as this is the first trial, cases in which bronchoplasty
or angioplasty was anticipated were excluded. The present
study was approved by our institutional review board and com-
plete informed consent on this trial of thoracoscopy for surgi-
cal treatment of lung cancer was obtained from each patient.
With a small skin incision 7 to 8 cm in length, the right fifth
intercostal space was entered just below the lower angle of
the scapular bone. Respiratory muscles and ribs were not sev-
ered. Two additional thoracoports were placed in the fourth
and seventh intercostal spaces at the anterior and mid to pos-
terior axillary lines, respectively. Through the small wound
and the 2 thoracoports, a designated pulmonary lobe(s) was
resected with hilar and mediastinal lymph node dissection
(VATS lobectomy with lymph node dissection). In most
cases, the pulmonary vein and bronchus were transected with
staplers and branches of pulmonary artery were ligated and
transected through the small thoracotomy wound. After VATS
lobectomy with lymph node dissection, a standard thoracoto-
my was subsequently carried out by a different surgeon to
complete systematic nodal dissection.
At VATS lobectomy, the number of dissected lymph nodes
at each station and the weight of dissected tissues including
fat tissue were recorded. The location and the number of
remaining lymph nodes and the weight of dissected tissues
found at additional thoracotomy were recorded as well. Per-
cent of remaining nodes was calculated both for number and
for weight. Operating time required for VATS lobectomy with
lymph node dissection and the amount of bleeding during the
procedure were also recorded.
Results. To date, 6 patients have been treated. The primary
lesion was located in the upper lobe in 5 patients and in the
middle lobe in the other patient. Upper lobectomy was per-
formed in 4 patients and upper and middle lobectomy in 2
patients. Clinical stage was T1 N0 M0 in all patients (Table I).
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Table I. Profile of patients and the disease state in the
present study
Primary Operative 
site Pathology cTNM procedure
1 (71, M) Upper lobe Adenocarcinoma T1 N0 M0 RUML
2 (68, F) Upper lobe Adenocarcinoma T1 N0 M0 RUL
3 (60, F) Upper lobe Adenocarcinoma T1 N0 M0 RUML
4 (68, F) Upper lobe Adenocarcinoma T1 N0 M0 RUL
5 (79, F) Middle lobe Adenocarcinoma T1 N0 M0 RML
6 (76, F) Upper lobe Adenocarcinoma T1 N0 M0 RUL
RUML, Right upper and middle lobectomy; RUL, right upper lobectomy;
RML, right middle lobectomy.
